On September 21, 2017, Stanley Yarbro announced that on August 25, 2017, he has stated that following Calmare Therapeutics Incorporated’s abrupt cancellation of the August 24th meeting, Stanley Yarbro, made a formal demand under Section 220 of the General Laws of the State of Delaware to review the stockholder list of the Company.